Last updated: 2026-09-08 13:25:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.05, with a market capitalisation of $861.30K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $16.68. This page covers its latest market performance, valuation, price trends and company information.
$861.30K | |
$0.83 | |
$200,000.00 | |
$0.82 | |
$0.83 | |
31.83M | |
4.85M | |
-- | |
$16.68 | |
$0.82 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) is trading at $1.05 in pre-market trading as of 2026-09-08 13:23:00, up 25.54% ($0.21) from the previous close of $0.83
Pre-market trading shows how investors are pricing BJDX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $0.91 to $1.05, representing a gain of 14.90% ($0.14).
The stock traded between $0.82 and $1.24 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 1.82 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.4%
BJDX is currently trading at $1.05, placing it 1.4% of the way from its 52-week low of $0.82 to its 52-week high of $16.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.